Affibody Medical AB Sustainability Reports
Affibody Medical AB is a clinical-stage biotechnology company that develops next-generation biologics and radiopharmaceuticals based on its proprietary technology platform. The company advances targeted therapeutic candidates focused primarily on oncology and immunology indications.
Sector: Professional & technical services
Country: Sweden
Exchange: Unlisted
LEI: 549300C3Z05RZW6LD903
1 reports from 2025 to 2025
